Ankylosing Spondylitis
📧 Sign up to get email alerts when something new happens for Ankylosing Spondylitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-11-04Clinical Trial Update: Efficacy and Safety of Adalimumab in Adult Chinese Subjects With Active Ankylosing Spondylitis [Phase 3]
A Phase 3 trial evaluated the efficacy and safety of Adalimumab in adult Chinese patients with active Ankylosing Spondylitis, with results p…
-
FDA approval · 2011-10-31FDA Approved: MELOXICAM — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Meloxicam from Aurobindo Pharma Limited. This approval updates the approved product under th…
-
FDA approval · 2011-09-19FDA Approved: NAPROXEN — Original Application (Cipla USA Inc.)
FDA approves Cipla USA Inc.'s Naproxen under Original Application, making a generic naproxen product available. It is used to relieve pain a…
-
FDA approval · 2011-09-07FDA Approved: CIMZIA — Supplemental Application (UCB, Inc.)
FDA approved a supplemental application for Cimzia (certolizumab pegol) submitted by UCB, Inc. This action approves the changes described in…
-
FDA approval · 2011-09-07FDA Approved: SIMPONI — Supplemental Application (Janssen Biotech, Inc.)
The FDA approved a supplemental application for SIMPONI (golimumab) filed by Janssen Biotech, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-08-24FDA Approved: NAPROXEN — Original Application (Exelan Pharmaceuticals, Inc.)
The FDA approved Exelan Pharmaceuticals' original ANDA for Naproxen (generic naproxen). This confirms a generic naproxen product for arthrit…
-
CLINICAL_TRIALS trial_result · 2011-08-23Clinical Trial Update: Study Of Celecoxib Or Diclofenac For Efficacy and Safety In Chinese Patients With Ankylosing Spondylitis [Phase 3]
Phase 3 trial comparing celecoxib and diclofenac for efficacy and safety in Chinese patients with ankylosing spondylitis has completed with …
-
CLINICAL_TRIALS research · 2011-08-19Clinical Trial Update: Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Ankylosing Spondylitis (AS) [Phase 1]
Phase 1 clinical trial evaluating the safety and efficacy of umbilical cord/placenta-derived mesenchymal stem cells for ankylosing spondylit…
-
CLINICAL_TRIALS trial_result · 2011-07-28Clinical Trial Update: Study Evaluating the Safety of Etanercept in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis
This document reports a safety-focused update for a terminated trial evaluating etanercept in rheumatoid arthritis, ankylosing spondylitis, …
-
CLINICAL_TRIALS trial_result · 2011-07-26Clinical Trial Update: Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS) After Unsustainable Response to Biologicals and Disease Modifying Antirheumatic Drugs
This trial update reports quality-of-life outcomes for Humira (adalimumab) in rheumatoid arthritis, psoriatic arthritis, and ankylosing spon…
-
CLINICAL_TRIALS trial_result · 2011-07-07Clinical Trial Update: Investigation of 9 Consecutive Remicade Infusions in Ankylosing Spondylitis in Austria (Study P04044)(COMPLETED)
The study P04044 investigating nine consecutive Remicade infusions for ankylosing spondylitis in Austria has completed, with results posted …
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: A Study of Infliximab (Remicade) in Patients With Ankylosing Spondylitis. [Phase 3]
This update reports the completion of a Phase 3 trial evaluating infliximab (Remicade) in patients with ankylosing spondylitis.
-
CLINICAL_TRIALS trial_result · 2011-04-26Clinical Trial Update: Observational Non-Interventional Study With Enbrel (Etanercept) in Patients With Ankylosing Spondylitis
This document reports the completion and posting of results for an observational non-interventional study of etanercept (Enbrel) in patients…
-
FDA approval · 2011-02-17FDA Approved: INFLIXIMAB — Supplemental Application (Janssen Biotech, Inc.)
The FDA approved a supplemental application for infliximab from Janssen Biotech, Inc., signaling a labeling update or expansion of its appro…
-
CLINICAL_TRIALS trial_result · 2011-02-04Clinical Trial Update: Etanercept (Enbrel) in Ankylosing Spondylitis [Phase 2]
A Phase 2 clinical trial evaluating etanercept (Enbrel) for ankylosing spondylitis, sponsored by Charité University Berlin; current trial st…
-
CLINICAL_TRIALS trial_result · 2011-01-31Clinical Trial Update: European Ankylosing Spondylitis Infliximab Cohort (EASIC) Follow up Registration Study
Clinical trial update for the European Ankylosing Spondylitis Infliximab Cohort (EASIC) follow-up registration study; the current status is …
-
FDA approval · 2010-12-28FDA Approved: INFLIXIMAB — Supplemental Application (Janssen Biotech, Inc.)
FDA approved Janssen Biotech, Inc.'s supplemental application for infliximab. The approval updates the product's labeling and indications as…
-
FDA approval · 2010-12-01FDA Approved: DICLOFENAC SODIUM — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original ANDA for Diclofenac Sodium (generic diclofenac) from Rising Pharma Holdings, Inc., providing a generic diclofenac …
-
CLINICAL_TRIALS trial_result · 2010-11-30Clinical Trial Update: Study Evaluating Epidemiology of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in Australia
A completed epidemiology study in Australia evaluated rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis; the sponsor Wye…
-
FDA approval · 2010-10-26FDA Approved: MELOXICAM — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for MELOXICAM (meloxicam) from Zydus Pharmaceuticals USA Inc., resulting in changes to the labeling.…
-
FDA approval · 2010-08-12FDA Approved: NAPROXEN SODIUM — Supplemental Application (Bionpharma Inc.)
The FDA approved a supplemental application for Naproxen Sodium submitted by Bionpharma Inc.
-
CLINICAL_TRIALS trial_result · 2010-08-11Clinical Trial Update: A Study of Adalimumab in Japanese Subjects With Active Ankylosing Spondylitis [Phase 3]
Phase 3 trial of adalimumab in Japanese patients with active ankylosing spondylitis completed; results posted in 2010.
-
CLINICAL_TRIALS research · 2010-08-06Clinical Trial Update: Frequency of Axial Spondyloarthropathy Among Patients Suffering From Fibromyalgia
This clinical trial update examines how frequently axial spondyloarthritis occurs in patients diagnosed with fibromyalgia, highlighting pote…
-
FDA approval · 2010-07-29FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
The FDA has approved a supplemental application for HUMIRA (adalimumab) filed by Cordavis Limited.
-
FDA approval · 2010-07-06FDA Approved: DICLOFENAC SODIUM — Supplemental Application (Edenbridge Pharmaceuticals LLC.)
FDA approved a supplemental application for diclofenac sodium from Edenbridge Pharmaceuticals LLC under the ANDA program. This action consti…